HomeCompareSPLP vs JNJ

SPLP vs JNJ: Dividend Comparison 2026

SPLP yields 3.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $6.2K in total portfolio value· pulled ahead in Year 8
10 years
SPLP
SPLP
● Live price
3.00%
Share price
$50.05
Annual div
$1.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.2K
Annual income
$363.54
Full SPLP calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — SPLP vs JNJ

📍 JNJ pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPLPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPLP + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPLP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPLP
Annual income on $10K today (after 15% tax)
$254.75/yr
After 10yr DRIP, annual income (after tax)
$309.01/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, JNJ beats the other by $3,728.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPLP + JNJ for your $10,000?

SPLP: 50%JNJ: 50%
100% JNJ50/50100% SPLP
Portfolio after 10yr
$27.3K
Annual income
$2,556.71/yr
Blended yield
9.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPLP
No analyst data
Altman Z
1.3
Piotroski
8/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPLP buys
0
JNJ buys
0
No recent congressional trades found for SPLP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPLPJNJ
Forward yield3.00%2.14%
Annual dividend / share$1.50$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$24.2K$30.5K
Annual income after 10y$363.54$4,749.88
Total dividends collected$3.3K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPLP vs JNJ ($10,000, DRIP)

YearSPLP PortfolioSPLP Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,000$299.70$10,594$274.49+$406.00SPLP
2$12,078$308.09$11,294$360.69+$784.00SPLP
3$13,239$316.16$12,133$476.91+$1.1KSPLP
4$14,490$323.89$13,156$635.42+$1.3KSPLP
5$15,836$331.30$14,432$854.61+$1.4KSPLP
6$17,283$338.38$16,056$1,162.76+$1.2KSPLP
7$18,837$345.14$18,175$1,604.53+$662.00SPLP
8← crossover$20,508$351.58$21,009$2,252.68$501.00JNJ
9$22,301$357.71$24,911$3,229.73$2.6KJNJ
10$24,225$363.54$30,458$4,749.88$6.2KJNJ

SPLP vs JNJ: Complete Analysis 2026

SPLPStock

Steel Partners Holdings L.P., through its subsidiaries, engages in industrial products, energy, defense, supply chain management, logistics, banking, and youth sports businesses worldwide. It operates through Diversified Industrial, Energy, and Financial Services segments. The company fabricates precious metals and alloys into brazing alloys; manufactures and sells seamless stainless steel tubing coils; fasteners, adhesives, and fastening systems for the commercial low slope roofing industry, as well as specialty fasteners for the building products industry; and woven substrates of fiberglass, quartz, carbon, and aramid materials for specialty applications. It also designs, manufactures, and markets power electronics and protection, motion control, power quality electromagnetic equipment, custom ball-screws, and gears and gearboxes used in medical, commercial and military aerospace, computer, datacom, industrial, specialty LED lighting, test and measurement, and telecom applications. In addition, the company provides meat-room blade products, repair services, and distributed products for the meat and deli departments of supermarkets, restaurants, and meat and fish processing plants, as well as for electrical saws and cutting equipment distributors; cutting blades for bakeries; and wood cutting blade products for the pallet manufacturing, pallet recycler, and portable saw mill industries. Further, it manufactures and distributes coated, laminated and metallized films for imaging, aerospace, insulation and solar photo-voltaic markets; originates and funds consumer and small business loans; issues credit cards; takes deposits; participates in syndicated commercial and industrial, and asset based credit facilities and securitizations; and offers drilling and production services to the oil and gas industry. Steel Partners Holdings GP Inc. serves as the general partner of the company. The company was founded in 1990 and is based in New York, New York.

Full SPLP Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SPLP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPLP vs SCHDSPLP vs JEPISPLP vs OSPLP vs KOSPLP vs MAINSPLP vs ABBVSPLP vs MRKSPLP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.